Dermavant Sciences, Inc. is committed to conducting our business in an ethical and legal manner with the highest level of integrity.
To ensure compliance with the laws, industry guidelines, and Dermavant standards applicable to the development, manufacturing, marketing, and sale of our products, the Company has established a Comprehensive Compliance Program (CCP) that is consistent with the Department of Health and Human Services Office of Inspector General Guidance. Our CCP is one of the key components of our commitment to the highest standards of conduct.
The Dermavant CCP, comprised of Dermavant’s Code of Business Conduct and Ethics, Compliance Manuals, and various policies and procedures, contains the ethical and legal standards to which all Dermavant employees must adhere. Our CCP is dynamic; we regularly review and enhance our CCP to meet our evolving compliance needs. The purpose of our CCP is to prevent and detect violations of law or Company policy. As HHS-OIG calls for in its Guidance, we have tailored our CCP to fit the specific nature of our business. The Company has designated compliance personnel, including a Chief Compliance Officer, with responsibility for developing, operating, monitoring, and enforcing this program. The Chief Compliance Officer or designee makes periodic reports to the Company’s Corporate Compliance Committee and reports significant issues directly to the Chief Executive Officer, the Executive Leadership Team, and/or the Audit Committee. The Company provides a toll-free telephone line and website to report suspected violations of Company policies or laws. Calls can be made anonymously and without fear of retribution 24-hours a day, 7-days a week. Allegations of non-compliance are documented and investigated so that appropriate corrective action can be taken when warranted.